Haemonetics Corp Earnings

Haemonetics Corp’s revenue jumped 8.59% since last year same period to $345.51Mn in the Q3 2024. On a quarterly growth basis, Haemonetics Corp has generated 2.78% jump in its revenue since last 3-months.

Haemonetics Corp’s net profit jumped 35.82% since last year same period to $33.83Mn in the Q3 2024. On a quarterly growth basis, Haemonetics Corp has generated -11.84% fall in its net profits since last 3-months.

Haemonetics Corp’s net profit margin jumped 25.08% since last year same period to 9.79% in the Q3 2024. On a quarterly growth basis, Haemonetics Corp has generated -14.22% fall in its net profit margins since last 3-months.

Haemonetics Corp’s earning per share (EPS) estimates for the current quarter stand at 1.07 - a 5.94% jump from last quarter’s estimates.

Haemonetics Corp’s earning per share (EPS) estimates for the current year stand at 1.07.

Haemonetics Corp’s earning per share (EPS) jumped 13.13% since last year same period to 1.12 in the Q3 2024. This indicates that the Haemonetics Corp has generated 13.13% annual rate of jump in its earning per share (EPS) in the last 4 quarters.